MSKLX Mutual Fund

MSKLX Mutual Fund

NAV$12.40
See how much of MSKLX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$9M
Expense Ratio
1.56%
Dividend Yield (Current)
-
Holdings
44
Inception Date
Jun 14, 2012
Fund Family
Morgan Stanley Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Semi-Annually

Performance

YTD+0.64%
1 Year-8.09%
3 Year+24.07%
5 Year-5.60%
10 Year+12.12%

Asset Allocation

Stocks: 95.67%
Cash: 2.39%
Other: 1.94%
See how much of MSKLX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
NETCloudflare Inc (180 Day Lockup)13.90%
RPRXRoyalty Pharma9.29%
AFRMAffirm Holdings Inc Class A7.46%
AURAurora Innovation Inc7.11%
IONQIonq, Inc. Pipe6.03%
Top 10 Concentration: 66.16%Report Date: Jun 30, 2026
Download all 44 holdings for MSKLX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Semi-Annually
Latest Distribution
$10.11
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

MSKLX Mutual Fund Overview

MSKLX Mutual Fund (MSIFT Discovery Portfolio Class L) is managed by Morgan Stanley Investment Management with $8.9M in net assets. MSKLX expense ratio is 1.56%, holding 44 positions across sectors including Information Technology, Health Care, Financials. Inception date: 2012-06-14.

MSKLX performance shows a YTD return of 0.64%. The 1-year return is -8.09% and the 5-year return is -5.60%.

MSKLX top holdings include Cloudflare Inc (180 Day Lockup) (13.9%), Royalty Pharma (9.3%), Affirm Holdings Inc Class A (7.5%), Aurora Innovation Inc (7.1%), Ionq, Inc. Pipe (6.0%). Go to all MSKLX holdings, MSKLX sectors, or MSKLX dividends.

MSKLX can be compared against other funds. Use MSKLX overlap to find shared positions, or MSKLX vs another fund for a side-by-side view. MSKLX alternatives are available via the screener, along with tax-loss harvesting opportunities.